HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,130 | +82.9% | 96,206 | +62.6% | 0.41% | +83.8% |
Q2 2023 | $6,085 | -49.4% | 59,164 | -46.3% | 0.22% | -49.4% |
Q1 2023 | $12,023 | +75.0% | 110,164 | +82.4% | 0.44% | +74.2% |
Q4 2022 | $6,872 | -97.8% | 60,386 | +1074.1% | 0.25% | +2000.0% |
Q3 2022 | $318,000 | -20.5% | 5,143 | +2.6% | 0.01% | -20.0% |
Q2 2022 | $400,000 | +11.4% | 5,014 | +47.1% | 0.02% | +25.0% |
Q1 2022 | $359,000 | -54.5% | 3,408 | -53.4% | 0.01% | -57.1% |
Q4 2021 | $789,000 | -13.7% | 7,320 | -12.3% | 0.03% | -15.2% |
Q3 2021 | $914,000 | +11.3% | 8,345 | -4.8% | 0.03% | +17.9% |
Q2 2021 | $821,000 | -48.7% | 8,769 | -49.5% | 0.03% | -53.3% |
Q1 2021 | $1,599,000 | +20.4% | 17,377 | -4.3% | 0.06% | +9.1% |
Q4 2020 | $1,328,000 | +38.9% | 18,150 | +47.5% | 0.06% | +25.0% |
Q3 2020 | $956,000 | +230.8% | 12,306 | +136.7% | 0.04% | +193.3% |
Q2 2020 | $289,000 | – | 5,198 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |